{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:03:48Z","timestamp":1789232628466,"version":"build-2803163510"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL006193-02"],"award-info":[{"award-number":["HL006193-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01234","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T04:24:30Z","timestamp":1527827070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["Potential Immunological Links Between Psoriasis and Cardiovascular Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Aparna P.","family":"Sajja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya A.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Teague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"H867","DOI":"10.1152\/ajpheart.00774.2016","article-title":"Psoriasis as a human model of disease to study inflammatory atherogenesis","volume":"312","author":"Harrington","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database","volume":"31","author":"Mehta","year":"2010","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli","year":"2009","journal-title":"Br J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/archdermatol.2009.94","article-title":"Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality","volume":"145","author":"Prodanovich","year":"2009","journal-title":"Arch Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jaad.2012.05.016","article-title":"The impact of psoriasis on 10-year Framingham risk","volume":"67","author":"Mehta","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1468-3083.2008.02636.x","article-title":"Psoriasis and diabetes: a population-based cross-sectional study","volume":"22","author":"Cohen","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000111512","article-title":"Association between psoriasis and the metabolic syndrome. A cross-sectional study","volume":"216","author":"Cohen","year":"2008","journal-title":"Dermatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/archdermatol.2010.370","article-title":"Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003\u20132006","volume":"147","author":"Love","year":"2011","journal-title":"Arch Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1161\/01.CIR.97.21.2099","article-title":"American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee","volume":"97","author":"Eckel","year":"1998","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/0003319713520463","article-title":"Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease","volume":"66","author":"Maresca","year":"2015","journal-title":"Angiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/CIR.0000000000000223","article-title":"Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association","volume":"132","author":"Rao","year":"2015","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12967-014-0258-2","article-title":"Characterization of immune cells in psoriatic adipose tissue","volume":"12","author":"Rose","year":"2014","journal-title":"J Transl Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","article-title":"Inflammation impairs reverse cholesterol transport in vivo","volume":"119","author":"McGillicuddy","year":"2009","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1210\/jc.2006-2545","article-title":"Innate immunity modulates adipokines in humans","volume":"92","author":"Anderson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","article-title":"Inflammation modulates human HDL composition and function in vivo","volume":"222","author":"de la Llera Moya","year":"2012","journal-title":"Atherosclerosis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.metabol.2014.12.007","article-title":"Activation of innate immunity modulates insulin sensitivity, glucose effectiveness and pancreatic beta-cell function in both African ancestry and European ancestry healthy humans","volume":"64","author":"Ferguson","year":"2015","journal-title":"Metabolism"},{"key":"B27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db09-0367","article-title":"Experimental endotoxemia induces adipose inflammation and insulin resistance in humans","volume":"59","author":"Mehta","year":"2010","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT Coronary Angiography Study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imag"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3899\/jrheum.130457","article-title":"Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting","volume":"40","author":"Armstrong","year":"2013","journal-title":"J Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","article-title":"The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fimmu.2018.00139","article-title":"Immune-mediated inflammation promotes subclinical atherosclerosis in recent-onset psoriatic arthritis patients without conventional cardiovascular risk factors","volume":"9","author":"Kolliker Frers","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1186\/ar4676","article-title":"Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the psoriasis atherosclerosis and cardiometabolic disease initiative","volume":"16","author":"Rose","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis-2013-203433","article-title":"The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease","volume":"73","author":"Eder","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3899\/jrheum.170025","article-title":"Underestimation of risk of carotid subclinical atherosclerosis by cardiovascular risk scores in patients with psoriatic arthritis","volume":"45","author":"Shen","year":"2018","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11883-015-0557-y","article-title":"The link between inflammatory disorders and coronary heart disease: a look at recent studies and novel drugs in development","volume":"18","author":"Teague","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jacc.2017.07.750","article-title":"Unraveling vascular inflammation: from immunology to imaging","volume":"70","author":"Teague","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2013.10.023","article-title":"Subclinical cardiovascular disease in plaque psoriasis: association or causal link?","volume":"232","author":"Shaharyar","year":"2014","journal-title":"Atherosclerosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00403-010-1108-6","article-title":"Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial","volume":"303","author":"Boehncke","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamacardio.2017.1213","article-title":"Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography\/computed tomography","volume":"2","author":"Dey","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archdermatol.2011.119","article-title":"Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET\/CT): a pilot study","volume":"147","author":"Mehta","year":"2011","journal-title":"Arch Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1001\/jamadermatol.2016.1984","article-title":"Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis","volume":"152","author":"Hjuler","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","article-title":"Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes","volume":"152","author":"Mansouri","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.amjmed.2014.08.008","article-title":"Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities","volume":"127","author":"Shlyankevich","year":"2014","journal-title":"Am J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1479-5876-5-27","article-title":"Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis","volume":"5","author":"Chamian","year":"2007","journal-title":"J Transl Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1073\/pnas.0409569102","article-title":"Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris","volume":"102","author":"Chamian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1172\/JCI8633","article-title":"Skin innate immune system in psoriasis: friend or foe?","volume":"104","author":"Nickoloff","year":"1999","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1111\/j.1600-0625.2009.01016.x","article-title":"Functional characterization of T cells differentiated in vitro from bone marrow-derived CD34 cells of psoriatic patients with family history","volume":"19","author":"Zhang","year":"2010","journal-title":"Exp Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/01.CIR.103.11.1509","article-title":"Molecular fingerprint of interferon-gamma signaling in unstable angina","volume":"103","author":"Liuzzo","year":"2001","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1161\/CIRCULATIONAHA.104.498865","article-title":"Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome","volume":"111","author":"Methe","year":"2005","journal-title":"Circulation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am J Pathol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.104.533463","article-title":"Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis","volume":"112","author":"Hauer","year":"2005","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(-\/-) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-\/- mice","volume":"22","author":"King","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/01.CIR.103.21.2610","article-title":"T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia","volume":"103","author":"Huber","year":"2001","journal-title":"Circulation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am J Pathol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.imlet.2004.01.014","article-title":"Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts","volume":"93","author":"Numasaki","year":"2004","journal-title":"Immunol Lett"},{"key":"B81","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.imlet.2004.11.012","article-title":"Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells","volume":"98","author":"Takahashi","year":"2005","journal-title":"Immunol Lett"},{"key":"B82","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/eurheartj\/ehs399","article-title":"Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown","volume":"34","author":"Liuzzo","year":"2013","journal-title":"Eur Heart J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clim.2014.12.012","article-title":"Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome","volume":"157","author":"Zheng","year":"2015","journal-title":"Clin Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"B88","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J Pathol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17\u2009cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B92","first-page":"193","article-title":"Regulatory T cells in psoriasis","author":"Kagen","year":"2006","journal-title":"Ernst Schering Res Found Workshop"},{"key":"B93","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2007.03.546","article-title":"The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes","volume":"124","author":"Han","year":"2007","journal-title":"Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/ATVBAHA.112.251579","article-title":"Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke","volume":"32","author":"Wigren","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"34157","DOI":"10.1074\/jbc.M112.382978","article-title":"Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome","volume":"287","author":"Zhang","year":"2012","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97179","article-title":"Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis","volume":"3","author":"Baumer","year":"2018","journal-title":"JCI Insight"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1161\/ATVBAHA.115.306460","article-title":"Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET\/CT and neutrophil activation in a prospective observational study","volume":"35","author":"Naik","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/ATVBAHA.114.303566","article-title":"Dendritic cells in atherosclerosis: evidence in mice and humans","volume":"35","author":"Zernecke","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1172\/JCI29441","article-title":"Misbehaving macrophages in the pathogenesis of psoriasis","volume":"116","author":"Clark","year":"2006","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1172\/JCI75005","article-title":"Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression","volume":"127","author":"Rahman","year":"2017","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","article-title":"Monocytes in coronary artery disease and atherosclerosis: where are we now?","volume":"62","author":"Ghattas","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/eurheartj\/ehw085","article-title":"Neutrophil-macrophage cross-talk in acute myocardial infarction","volume":"38","author":"Frodermann","year":"2017","journal-title":"Eur Heart J"},{"key":"B107","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aac7801","article-title":"Immunology. Neutrophil-macrophage communication in inflammation and atherosclerosis","volume":"349","author":"Nahrendorf","year":"2015","journal-title":"Science"},{"key":"B108","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: a paradigm shift?","volume":"23","author":"Keijsers","year":"2014","journal-title":"Exp Dermatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1600-0625.2012.01571.x","article-title":"Novel insights into the role of S100A8\/A9 in skin biology","volume":"21","author":"Kerkhoff","year":"2012","journal-title":"Exp Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11883-017-0692-8","article-title":"Emerging associations between neutrophils, atherosclerosis, and psoriasis","volume":"19","author":"Sanda","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"B114","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity","volume":"35","author":"Carmona-Rivera","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1002\/art.23961","article-title":"Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures","volume":"58","author":"Nakou","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B116","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: an overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"Doring","year":"2017","journal-title":"Circ Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2017.00928","article-title":"Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis","volume":"8","author":"Qi","year":"2017","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/eurheartj\/ehv044","article-title":"TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion","volume":"36","author":"Quillard","year":"2015","journal-title":"Eur Heart J"},{"key":"B123","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0148607108325251","article-title":"Adipose inflammation, insulin resistance, and cardiovascular disease","volume":"32","author":"Shah","year":"2008","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B124","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcmg.2017.08.014","article-title":"Visceral adiposity in psoriasis is associated with vascular inflammation by 18fluorodeoxyglucose positron-emission tomography\/computed tomography beyond cardiometabolic disease risk factors in an observational cohort study","volume":"11","author":"Rivers","year":"2017","journal-title":"J Cardiovasc Imag"},{"key":"B125","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/CIRCULATIONAHA.107.724096","article-title":"Remodeling phenotype of human subcutaneous adipose tissue macrophages","volume":"117","author":"Bourlier","year":"2008","journal-title":"Circulation"},{"key":"B126","doi-asserted-by":"publisher","first-page":"309548","DOI":"10.1155\/2014\/309548","article-title":"Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity","volume":"2014","author":"Fjeldborg","year":"2014","journal-title":"J Immunol Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2217\/clp.10.89","article-title":"Perivascular adipose tissue and vascular disease","volume":"6","author":"Britton","year":"2011","journal-title":"Clin Lipidol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e000582","DOI":"10.1161\/JAHA.113.000582","article-title":"Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations","volume":"3","author":"Fitzgibbons","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1161\/01.ATV.0000188508.40052.35","article-title":"Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?","volume":"25","author":"Henrichot","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/ATVBAHA.110.204719","article-title":"Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells","volume":"30","author":"Karastergiou","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"eaal2658","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1365-2133.2008.08742.x","article-title":"Serum leptin levels, skin leptin and leptin receptor expression in psoriasis","volume":"159","author":"Cerman","year":"2008","journal-title":"Br J Dermatol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jaad.2014.06.006","article-title":"Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: is psoriasis associated with atherosclerosis?","volume":"71","author":"Robati","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12944-016-0271-y","article-title":"Epicardial fat tissue in patients with psoriasis: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2016","journal-title":"Lipids Health Dis"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1517\/14712598.2013.853739","article-title":"Biological therapies for psoriasis","volume":"13","author":"Mansouri","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"B137","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/bjd.14964","article-title":"Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials","volume":"176","author":"Rungapiromnan","year":"2017","journal-title":"Br J Dermatol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/09546634.2014.952609","article-title":"Risk of myocardial infarction in psoriasis patients: a retrospective cohort study","volume":"26","author":"Wu","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14951","article-title":"Anti-inflammatory therapy with tumor necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis","author":"Wu","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/archdermatol.2012.2502","article-title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis","volume":"148","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis \u2013 shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"E81","DOI":"10.3390\/jcm6090081","article-title":"IL-23 and Th17 disease in inflammatory arthritis","volume":"6","author":"Yago","year":"2017","journal-title":"J Clin Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jid.2018.03.400","article-title":"A trial to determine the effect of psoriasis treatment (adalimumab, phototherapy, and placebo) on cardiometabolic disease: the vascular inflammation in psoriasis (VIP) trial","volume":"138","author":"Gelfand","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/jim-2018-000730.1","article-title":"A phase IV, randomised, double-blind, placebocontrolled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U TRIAL)","volume":"66","author":"Gelfand","year":"2018","journal-title":"J Invest Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T04:24:35Z","timestamp":1527827075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2018.01234"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01234","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"article-number":"1234"}}